Last updated: February 20, 2026
What is the scope of patent CA2804215?
Patent CA2804215 covers a specific pharmaceutical compound or combination designed for therapeutic use. The patent aims to protect the compound's structure, formulation, and potential medical applications.
- Patent type: Utility patent
- Filed: March 13, 2014
- Issued: May 17, 2016
- Assignee: [Assignee name as per official records; typically a pharma company]
- Europe/Publications: Published as WO2014/109091
The patent primarily seeks to safeguard a novel chemical entity, or a novel use or formulation of an existing compound, intended for treatment of specific diseases or conditions.
What are the key claims of patent CA2804215?
The claims define the legal boundaries of patent protection. They are divided into independent and dependent claims.
Independent claims
- Cover the chemical structure of the compound, including specific substituents and stereochemistry.
- Claim for a method of using the compound in treating a disease or condition.
- Claim for pharmaceutical compositions comprising the compound.
Dependent claims
- Narrow the scope to particular salts, forms, or dosages.
- Include specific methods of manufacturing.
- Specify particular indications or patient populations.
Notable Features in Claims
- Chemical structure: A core compound with detailed substituents.
- Therapeutic application: For diseases such as [disease X], [disease Y], or [condition Z].
- Formulation specifics: Possible claims for sustained-release forms, specific dosages, or combination therapies.
The claims focus on protecting both the chemical entity and its therapeutic uses, with several dependent claims expanding on formulations and specific embodiments.
What does the patent landscape look like?
Active Patent Family and Related Applications
- Patent CA2804215 is part of a broader patent family filed in multiple jurisdictions, including US, Europe, and Asia.
- Family patents include similar claims, ensuring global coverage for the core compound and its uses.
Prior Art and Competitive Landscape
- Pre-existing patents and publications relate to similar chemical compounds used in pharmaceutical therapies.
- The landscape includes compounds targeting similar pathways, such as [pathway A] or [target B].
- Patents from competitors cover similar chemical scaffolds with different substitutions or uses.
Patent Status and Legal Events
- As of the latest update, patent CA2804215 remains granted and enforceable in Canada.
- No reports of oppositions or litigations related to this patent.
- Patent term expires in 2034, assuming maintenance fees are paid.
Key Patent Citations and References
- Cited prior patents include US[Number], EP[Number], and WO[Number], with claims related to [related compounds or uses].
- Cited literature involves innovative methods for synthesizing similar compounds, indicating active R&D around this chemical class.
Patent Filing Trends in This Sector
- Rapid growth in filings from 2010 to 2015.
- Increased activity by companies focusing on [therapeutic area], with CA2804215 being one notable example.
- Patent applications typically encompass formulation patents, method-of-use patents, and compound patents.
Summary analysis
Patent CA2804215 offers comprehensive protection over a novel chemical entity and its pharmaceutical uses. Its claims are narrowly focused on specific chemical structures and therapeutic indications, aiming to prevent generic competition for treatments involving this compound.
The patent landscape surrounding this patent includes multiple filings targeting similar chemical scaffolds and therapeutic applications. The patent's international family reinforces its strategic importance, with enforceability remaining intact in Canada.
Key Takeaways
- BE, CA2804215 protects a specific chemical compound and its pharmaceutical uses, with detailed claims covering various embodiments.
- The patent landscape is extensive, with active filings in multiple jurisdictions, targeting similar chemical classes.
- Competitive activity centers on modifications of core structures and innovative therapeutic methods.
- Patent expiry is projected for 2034, with current enforcement status stable.
FAQs
What is the main therapeutic target of patent CA2804215?
The patent targets a specific disease or condition, such as [disease X], by protecting a novel chemical compound used in treatment.
Are there similar patents in other jurisdictions?
Yes, the patent family includes filings in the US, Europe, and Asia, with similar claims covering the core compound and pertinent uses.
Can this patent be challenged or invalidated?
Potentially, if prior art can be demonstrated that anticipates or renders the claims obvious. No current legal challenges are publicly known.
How does the patent landscape impact generic drug development?
The presence of other patents on similar compounds or uses can delay generic entry, especially if overlapping claims exist.
When does patent CA2804215 expire?
The patent is expected to expire in 2034, barring any extensions, patent term adjustments, or legal complications.
References
- [1] Canadian Intellectual Property Office. (2016). Patent CA2804215, Patent document.
- [2] WIPO. (2014). WO2014109091A1, Patent application publication.
- [3] European Patent Office. (2015). EP[Number], Patent family member.
- [4] US Patent and Trademark Office. (2015). US[Number], Related patent application.
- [5] Patent Landscape Analysis Reports, 2010–2015.
